Latest filing published 21 May 2026 for ClearPoint Neuro, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of B. Kristine Johnson across 4 companies, led by ClearPoint Neuro, Inc., ViewRay, Inc. and AtriCure, Inc. We count 29 filings; the first trade dates from 20 May 2021 and the latest from 19 May 2026.
On the open market, the record shows 2 purchases worth €217k and 2 sales worth €6,468. Netting one side against the other leaves €211k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 21 share grants and 3 option exercises.
Most recently, on 21 May 2026, the filings show an option exercise in ClearPoint Neuro, Inc. The most recent open-market purchase was published on 13 May 2022, 1,619 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations